Advertisement
UK markets close in 8 hours 9 minutes
  • FTSE 100

    8,363.44
    +9.39 (+0.11%)
     
  • FTSE 250

    20,489.94
    -2.05 (-0.01%)
     
  • AIM

    782.22
    +2.39 (+0.31%)
     
  • GBP/EUR

    1.1624
    +0.0001 (+0.01%)
     
  • GBP/USD

    1.2483
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    49,265.62
    -698.96 (-1.40%)
     
  • CMC Crypto 200

    1,311.58
    +11.48 (+0.88%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CRUDE OIL

    79.46
    +0.47 (+0.60%)
     
  • GOLD FUTURES

    2,320.10
    -2.20 (-0.09%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,519.71
    +205.85 (+1.12%)
     
  • DAX

    18,552.04
    +53.66 (+0.29%)
     
  • CAC 40

    8,133.18
    +1.77 (+0.02%)
     

Startup Battlefield Finals at Disrupt 2021 - Cellino

Cellino is on a mission to make personalized, autologous cell therapies accessible for patients. Stem cell-derived regenerative medicines will cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures. Cellino’s platform uses AI-guided lasers to make personalized regenerative medicines at scale for the first time.